Projects We Have Joined

Participation in Global Health Innovative Technology Fund (GHIT Fund)

News Release: Chugai - A*STAR Joint Development Project for Anti-Dengue Virus Antibody Continuously Selected as Grant Recipient by GHIT Fund (Mar. 29, 2019)

News Release: Participation in the Global Health Innovative Technology Fund (GHIT Fund) (Dec. 24, 2014) [PDF 120KB]

GHIT Fund is a public-private partnership to support research and development of pharmaceuticals, vaccines and diagnostics for serious diseases in developing countries. It utilizes Japan’s medical technology, innovation and knowledge more directly. (https://www.ghitfund.org/)

Participation in Access Accelerated

News Release: Chugai to Join Global Initiative for Addressing Rise of Non-Communicable Diseases in Low and Lower-Middle Income Countries (Jan. 18, 2017)

To work on the United Nations Sustainable Development Goal to reduce premature deaths from non-communicable diseases (NCDs) by one-third by 2030, 22 leading global biopharmaceutical companies launched Access Accelerated. It is a global initiative to advance access to NCD prevention information, diagnosis and care in low and middle-income countries. (https://accessaccelerated.org/)

Participation in WFH (World Federation of Hemophilia) Humanitarian Aid Program

News Release: Together with Roche, Chugai Joins the World Federation of Hemophilia Humanitarian Aid Program (Feb. 06, 2019)

WFH Humanitarian Aid Program is a landmark initiative leading the effort to improve access to care and treatment for people with inherited bleeding disorders in developing countries where access to treatment is limited.

  • Like
  • Tweet
  • LINE it!
  • E-mail

Global Health

Back to top